Q2 EPS Estimates for AngioDynamics Raised by Zacks Research
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research upped their Q2 2026 earnings estimates for shares of AngioDynamics in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst D. Dey now anticipates that the medical instruments supplier will earn ($0.10) per share for the quarter, […]
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Stock analysts at Zacks Research upped their Q2 2026 earnings estimates for shares of AngioDynamics in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst D. Dey now anticipates that the medical instruments supplier will earn ($0.10) per share for the quarter, […]
